Correlation Between Enlivex Therapeutics and Scully Royalty

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Scully Royalty at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Scully Royalty into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and Scully Royalty, you can compare the effects of market volatilities on Enlivex Therapeutics and Scully Royalty and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Scully Royalty. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Scully Royalty.

Diversification Opportunities for Enlivex Therapeutics and Scully Royalty

0.6

Correlation Coefficient

Enlivex Therapeutics  Scully Royalty

Poor diversification

The 3 months correlation between Enlivex and Scully is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Scully Royalty in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scully Royalty and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Scully Royalty. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scully Royalty has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Scully Royalty go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Scully Royalty

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Scully Royalty. In addition to that, Enlivex Therapeutics is 2.21 times more volatile than Scully Royalty. It trades about -0.01 of its total potential returns per unit of risk. Scully Royalty is currently generating about -0.02 per unit of volatility. If you would invest  787.00  in Scully Royalty on September 4, 2024 and sell it today you would lose (36.00) from holding Scully Royalty or give up 4.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.44%
Values	Daily Returns

Enlivex Therapeutics  vs.  Scully Royalty

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Enlivex Therapeutics is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Scully Royalty

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scully Royalty has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Scully Royalty is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Enlivex Therapeutics and Scully Royalty

The main advantage of trading using opposite Enlivex Therapeutics and Scully Royalty positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Scully Royalty can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scully Royalty will offset losses from the drop in Scully Royalty's long position.

The idea behind Enlivex Therapeutics and Scully Royalty pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.